BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25703353)

  • 1. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
    Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
    Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
    Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
    J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Human Bone Marrow Mesenchymal Stem Cells Secretome from Acute Myeloid Leukemia Patients on the Proliferation and Death of K562 and K562-Lucena Leukemia Cell Lineages.
    de Freitas FA; Levy D; Reichert CO; Sampaio-Silva J; Giglio PN; de Pádua Covas Lage LA; Demange MK; Pereira J; Bydlowski SP
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging.
    Bandyopadhyay S; Duffy MP; Ahn KJ; Sussman JH; Pang M; Smith D; Duncan G; Zhang I; Huang J; Lin Y; Xiong B; Imtiaz T; Chen CH; Thadi A; Chen C; Xu J; Reichart M; Martinez Z; Diorio C; Chen C; Pillai V; Snaith O; Oldridge D; Bhattacharyya S; Maillard I; Carroll M; Nelson C; Qin L; Tan K
    Cell; 2024 Jun; 187(12):3120-3140.e29. PubMed ID: 38714197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
    Zhao C; Du F; Zhao Y; Wang S; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells.
    Xu J; Li X; Cole A; Sherman Z; Du W
    Stem Cells; 2018 May; 36(5):785-795. PubMed ID: 29377497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities.
    Zhang L; Zhao Q; Cang H; Wang Z; Hu X; Pan R; Yang Y; Chen Y
    Adv Sci (Weinh); 2022 Jun; 9(16):2105811. PubMed ID: 35686138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
    Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
    Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.
    Yuan B; El Dana F; Ly S; Yan Y; Ruvolo V; Shpall EJ; Konopleva M; Andreeff M; Battula VL
    PLoS One; 2020; 15(11):e0242809. PubMed ID: 33253299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
    Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
    Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
    Wu L; Amarachintha S; Xu J; Oley F; Du W
    Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of Down syndrome-specific non-malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease.
    Hsu FC; Hudson C; Wilson ER; Pardo LM; Singleton TP; Xu D; Zehentner BK; Hitzler J; Berman J; Wells DA; Loken MR; Brodersen LE
    Cytometry B Clin Cytom; 2023 Jul; 104(4):311-318. PubMed ID: 37015883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML.
    Duarte D; Hawkins ED; Akinduro O; Ang H; De Filippo K; Kong IY; Haltalli M; Ruivo N; Straszkowski L; Vervoort SJ; McLean C; Weber TS; Khorshed R; Pirillo C; Wei A; Ramasamy SK; Kusumbe AP; Duffy K; Adams RH; Purton LE; Carlin LM; Lo Celso C
    Cell Stem Cell; 2018 Jan; 22(1):64-77.e6. PubMed ID: 29276143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia's biological functions: a focus on the potential role of LncRNAs.
    Jalilivand S; Izadirad M; Vazifeh Shiran N; Gharehbaghian A; Naserian S
    Clin Exp Med; 2024 May; 24(1):108. PubMed ID: 38777995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML alters bone marrow stromal cell osteogenic commitment via Notch signaling.
    Tomasoni C; Arsuffi C; Donsante S; Corsi A; Riminucci M; Biondi A; Pievani A; Serafini M
    Front Immunol; 2023; 14():1320497. PubMed ID: 38111584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.
    Wu CH; Weng TF; Li JP; Wu KH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Insights Into the Influence of Marrow Mesodermal/Mesenchymal Progenitor Cells on Acute Myelogenous Leukemia and Myelodysplastic Syndromes.
    Liesveld J; Galipeau J
    Stem Cells; 2023 Sep; 41(9):823-836. PubMed ID: 37348128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy.
    Forte D; García-Fernández M; Sánchez-Aguilera A; Stavropoulou V; Fielding C; Martín-Pérez D; López JA; Costa ASH; Tronci L; Nikitopoulou E; Barber M; Gallipoli P; Marando L; Fernández de Castillejo CL; Tzankov A; Dietmann S; Cavo M; Catani L; Curti A; Vázquez J; Frezza C; Huntly BJ; Schwaller J; Méndez-Ferrer S
    Cell Metab; 2020 Nov; 32(5):829-843.e9. PubMed ID: 32966766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.